compound management

The global compound control market is projected to reach $424.5 million in 2023 from $215.3m in 2018, at CAGR of 14.5 per cent.

Back due to popular demand, the co-location of IQPC’s 12th Annual Global BiobankingSummit alongside the Compound and Sample Management Conference took place last week.The two events provided an apt ca...

The pharmaceutical industry clearly understands there are issues associated with the R&D model that has existed for many years, and are actively investigating ways to dramatically improve the re...

Next generation compound management– Where do we go from here? As ageing compound management systems need to be renewed or replaced, companies are faced with different options from outsour...

A collection of 68 deprioritised pharmaceutical compounds1 is being made available to academic researchers through a partnership between the Medical Research Council (MRC) and seven global drug comp...

Create your free online surveys with SurveyMonkey , the world's leading questionnaire tool.[surveycode]

High Throughput Screening is growing rapidly as it becomes essential for new sectors and old areas find new applications for it. According to a new report titled High Throughput Screening (HTS) Mark...

Download the Compound and Sample Management ebook covering the topics compound management professionals worldwide are discussing including informatics systems, controlled substances, compliance, aut...

Creating a fit-for-purpose compound management and compound ordering system is a huge task, so often the best way to understand is to look at those who have done it before. We spoke to Claus Stie Ka...

Effective management of compound libraries remains crucial for drug innovation and discovery. In this podcast Timothy Dunne, Scientist, Pfizer, speaks to Andrea Charles from Pharma IQ, about the mai...

In this special report, we asked compound management leaders from Merck, GSK, Genentech and elsewhere to share insight on their main focus areas. Topics discussed: HTS, Controlled Substances, Collab...

Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D. - Ludovic Otterbein Ludovic Otterbein, Head of Global Compound Man...